Opportunities Knock On TCM Door
This article was originally published in PharmAsia News
Executive Summary
Guangzhou Xiangxue Pharmaceuticals has opened its Xiangxue traditional Chinese medicine research and development center in Cambridge, England. It will partner with the University of Cambridge and other academic institutions to investigate the science underpinning TCM efficacy, formulation standards, technical processes, and other related issues. This collaboration marks a significant step in China's focus to develop its TCM industry, earmarked as one of its strategic sectors. The current $30 billion international herbal market is growing at 10 percent to 20 percent annually and investors are eyeing the sector as a hot growth area. Many local listed enterprises are investing in TCM as an alternative strategy for transformation and expansion. (Click here for more)